Literature DB >> 32633228

[Diagnosis and Minimal Invasive Treatment of Benign Prostatic Hyperplasia].

Adrian Kobe1, Olivio Donati1, Thomas Pfammatter1.   

Abstract

Diagnosis and Minimal Invasive Treatment of Benign Prostatic Hyperplasia Abstract. Benign prostatic hyperplasia (BPH) is a common condition in men aged 50 - 60 years with a prevalence of about 50 %. After failure of conservative treatment, the standard treatment of BPH is transurethral resection of the prostate (TURP). However, over the last years prostatic artery embolization (PAE) emerged as a minimal invasive alternative to treat lower urinary tract symptoms. After patient assessment by MRI and CT of the prostate to rule out possible contraindications of PAE, the procedure can be performed in an outpatient setting under local anesthesia by an interventional radiologist. Especially for frail patients and / or patients with special risks regarding surgery / anesthesia, PAE may be an alternative to TURP with fewer complications.

Entities:  

Year:  2020        PMID: 32633228     DOI: 10.1024/0040-5930/a001152

Source DB:  PubMed          Journal:  Ther Umsch        ISSN: 0040-5930


  1 in total

1.  Urinary and sexual function changes in benign prostatic hyperplasia patients before and after transurethral columnar balloon dilatation of the prostate.

Authors:  Dong-Peng Zhang; Zheng-Bo Pan; Hai-Tao Zhang
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.